Fornefett Juliane, Banerji Sangeeta, Rimek Dagmar
Thuringian State Authority of Consumer Protection, Department of Health Protection, Bad Langensalza, Germany.
Robert Koch Institute, National Reference Center for Salmonella and Other Enteric Pathogens, Wernigerode, Germany.
GMS Infect Dis. 2025 Jun 17;13:Doc02. doi: 10.3205/id000092. eCollection 2025.
Foodborne campylobacteriosis is the most common cause of bacterial gastroenteritis in Germany. Due to increasing antibiotic resistance in , data of isolates of human origin are published by the European Center for Disease Control and Prevention (ECDC)/European Food Safety Authority (EFSA). However, data on susceptibility to meropenem, an antibiotic of last resort, is not included. Therefore, the minimal inhibitory concentration (MIC) for meropenem was measured in 125 () and 57 () isolates isolated from human stool samples between 2020 and 2023, comparing ellipsoid test and broth microdilution. Additionally, we determined the susceptibility of 249 and 84 strains isolated between 2018 and 2023 to erythromycin, ciprofloxacin and oxytetracycline by disk diffusion according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST). For meropenem, the MIC results of 5% isolates were interpreted as resistant. Erythromycin resistance was found in none versus 9 (11%) isolates that were resistant to all three substances. Ciprofloxacin and oxytetracycline resistance were detected in 72 and 41% , and 67 and 70% isolates, respectively. Only 24% and 13% isolates were susceptible to all three substances. The dual resistance of ciprofloxacin and oxytetracycline was the most common resistance pattern, observed in 37% and 38% isolates, respectively. None of the isolates was resistant to all four tested substances. Our data underline the need for susceptibility testing of to alternatively used antimicrobial substances in clinical laboratories. The ellipsoid test provides a good alternative for meropenem MIC testing, although borderline isolates should be confirmed using microdilution.
食源性弯曲杆菌病是德国细菌性肠胃炎最常见的病因。由于弯曲杆菌的抗生素耐药性不断增加,欧洲疾病预防控制中心(ECDC)/欧洲食品安全局(EFSA)公布了人类源分离株的数据。然而,关于作为最后手段的抗生素美罗培南的药敏数据并未包含在内。因此,我们测定了2020年至2023年间从人类粪便样本中分离出的125株空肠弯曲杆菌(C. jejuni)和57株结肠弯曲杆菌(C. coli)对美罗培南的最低抑菌浓度(MIC),并比较了椭圆检测法和肉汤微量稀释法。此外,我们根据欧洲抗菌药物敏感性试验委员会(EUCAST)的标准,通过纸片扩散法测定了2018年至2023年间分离出的249株空肠弯曲杆菌和84株结肠弯曲杆菌对红霉素、环丙沙星和土霉素的敏感性。对于美罗培南,5%的空肠弯曲杆菌分离株的MIC结果被判定为耐药。在对所有三种物质均耐药的空肠弯曲杆菌分离株中未发现对红霉素耐药的情况,而结肠弯曲杆菌中有9株(11%)对红霉素耐药。空肠弯曲杆菌中对环丙沙星和土霉素的耐药率分别为72%和41%,结肠弯曲杆菌中分别为67%和70%。只有24%的空肠弯曲杆菌和13%的结肠弯曲杆菌分离株对所有三种物质敏感。环丙沙星和土霉素的双重耐药是最常见的耐药模式,在空肠弯曲杆菌和结肠弯曲杆菌分离株中的发生率分别为37%和38%。没有分离株对所有四种测试物质均耐药。我们的数据强调了临床实验室对弯曲杆菌进行替代抗菌药物药敏试验的必要性。椭圆检测法为美罗培南MIC检测提供了一个很好的替代方法,不过临界分离株应使用微量稀释法进行确认。